FTLD targets brain regions expressing recently evolved genes

In frontotemporal lobar degeneration (FTLD), pathological protein aggregation is associated with a decline in human-specialized social-emotional and language functions. Most disease protein aggregates contain either TDP-43 (FTLD-TDP) or tau (FTLD-tau). Here, we explored whether FTLD targets brain re...

Full description

Bibliographic Details
Authors: Pasquini, Lorenzo, Pereira, Felipe L., Seddighi, Sahba, Zeng, Yi, Wei, Yongbin, Illán-Gala, Ignacio|||0000-0002-5418-2052, Vatsavayai, Sarat C., Friedberg, Adit, Lee, Alex J., Brown, Jesse A., Spina, Salvatore, Grinberg, Lea T., Sirkis, Daniel W., Bonham, Luke W., Yokoyama, Jennifer S.|||0000-0001-7274-2634, Boxer, Adam, Kramer, Joel H.|||0000-0002-2917-8297, Rosen, Howard J.|||0000-0001-9281-7402, Humphrey, Jack, Gitler, Aaron D., Miller, Bruce L.|||0000-0002-2152-4220, Pollard, Katherine S., Ward, Michael E., Seeley, William W.
Format: article
Publication Date:2023
Country:España
Institution:Universitat Autònoma de Barcelona
Repository:Dipòsit Digital de Documents de la UAB
Language:English
OAI Identifier:oai:ddd.uab.cat:291455
Online Access:https://ddd.uab.cat/record/291455
https://dx.doi.org/urn:doi:10.1101/2023.10.27.23297687
Access Level:Open access
Keyword:Cryptic exon
Frontotemporal lobar degeneration
Gene expression
Human accelerated regions
Tau
TDP-43
Description
Summary:In frontotemporal lobar degeneration (FTLD), pathological protein aggregation is associated with a decline in human-specialized social-emotional and language functions. Most disease protein aggregates contain either TDP-43 (FTLD-TDP) or tau (FTLD-tau). Here, we explored whether FTLD targets brain regions that express genes containing human accelerated regions (HARs), conserved sequences that have undergone positive selection during recent human evolution. To this end, we used structural neuroimaging from patients with FTLD and normative human regional transcriptomic data to identify genes expressed in FTLD-targeted brain regions. We then integrated primate comparative genomic data to test our hypothesis that FTLD targets brain regions expressing recently evolved genes. In addition, we asked whether genes expressed in FTLD-targeted brain regions are enriched for genes that undergo cryptic splicing when TDP-43 function is impaired. We found that FTLD-TDP and FTLD-tau subtypes target brain regions that express overlapping and distinct genes, including many linked to neuromodulatory functions. Genes whose normative brain regional expression pattern correlated with FTLD cortical atrophy were strongly associated with HARs. Atrophy-correlated genes in FTLD-TDP showed greater overlap with TDP-43 cryptic splicing genes compared with atrophy-correlated genes in FTLD-tau. Cryptic splicing genes were enriched for HAR genes, and vice versa, but this effect was due to the confounding influence of gene length. Analyses performed at the individual-patient level revealed that the expression of HAR genes and cryptically spliced genes within putative regions of disease onset differed across FTLD-TDP subtypes. Overall, our findings suggest that FTLD targets brain regions that have undergone recent evolutionary specialization and provide intriguing potential leads regarding the transcriptomic basis for selective vulnerability in distinct FTLD molecular-anatomical subtypes.